TABLE 2

Biodistribution of [18F]FHBG in Tumor-Bearing Mice at 5 Hours

TissueNontransduced tumor modelTransduced tumor model
%ID/gTumor-to-tissue ratio%ID/gTumor-to-tissue ratio
Blood0.017 ± 0.0011.58 ± 0.140.017 ± 0.00120.71 ± 1.06
Skin0.026 ± 0.0011.05 ± 0.070.030 ± 0.00111.52 ± 0.62
Muscle0.017 ± 0.0011.64 ± 0.120.022 ± 0.00322.23 ± 2.41
Bone0.225 ± 0.0150.13 ± 0.010.220 ± 0.0151.71 ± 0.15
Heart0.020 ± 0.0011.48 ± 0.150.023 ± 0.00115.74 ± 0.99
Lung0.031 ± 0.0020.89 ± 0.060.022 ± 0.00115.73 ± 0.93
Liver0.047 ± 0.0020.54 ± 0.020.034 ± 0.00211.23 ± 1.01
Spleen0.050 ± 0.0030.55 ± 0.040.043 ± 0.0039.08 ± 0.99
Pancreas0.028 ± 0.0031.46 ± 0.280.029 ± 0.00111.49 ± 0.51
Stomach0.050 ± 0.0030.84 ± 0.080.030 ± 0.00111.51 ± 0.68
Intestine0.064 ± 0.0050.47 ± 0.050.058 ± 0.0025.87 ± 0.27
Kidney0.054 ± 0.0020.49 ± 0.030.048 ± 0.0058.86 ± 1.11
Tumor0.025 ± 0.0100.335 ± 0.070*
  • * P < 0.001 compared with nontransduced tumor (Student t test on paired samples).

  • Data are mean ± SEM of 5 animals.